Login / Signup

Promising Objective Response Rates and Progression-Free Survival but Modest Overall Survival in the TAB Study.

Naohiro OkanoTomonori MizutaniShuichi Hironaka
Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Keyphrases
  • free survival